nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—TRPV1—nerve—acquired immunodeficiency syndrome	0.0297	0.0617	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—retina—acquired immunodeficiency syndrome	0.0185	0.0383	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—skin of body—acquired immunodeficiency syndrome	0.0162	0.0336	CbGeAlD
Alpha-Linolenic Acid—FADS2—retina—acquired immunodeficiency syndrome	0.0157	0.0326	CbGeAlD
Alpha-Linolenic Acid—FADS2—skin of body—acquired immunodeficiency syndrome	0.0138	0.0286	CbGeAlD
Alpha-Linolenic Acid—FABP7—retina—acquired immunodeficiency syndrome	0.0136	0.0282	CbGeAlD
Alpha-Linolenic Acid—FABP3—spinal cord—acquired immunodeficiency syndrome	0.0133	0.0277	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lymphoid tissue—acquired immunodeficiency syndrome	0.0131	0.0272	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—digestive system—acquired immunodeficiency syndrome	0.013	0.0269	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—blood—acquired immunodeficiency syndrome	0.0123	0.0256	CbGeAlD
Alpha-Linolenic Acid—FADS1—retina—acquired immunodeficiency syndrome	0.0123	0.0256	CbGeAlD
Alpha-Linolenic Acid—FABP3—lung—acquired immunodeficiency syndrome	0.0121	0.0252	CbGeAlD
Alpha-Linolenic Acid—Eructation—Stavudine—acquired immunodeficiency syndrome	0.0121	0.0234	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—spinal cord—acquired immunodeficiency syndrome	0.0119	0.0247	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—vagina—acquired immunodeficiency syndrome	0.0114	0.0238	CbGeAlD
Alpha-Linolenic Acid—FABP3—nervous system—acquired immunodeficiency syndrome	0.0112	0.0233	CbGeAlD
Alpha-Linolenic Acid—FABP3—central nervous system—acquired immunodeficiency syndrome	0.0108	0.0225	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lung—acquired immunodeficiency syndrome	0.0108	0.0225	CbGeAlD
Alpha-Linolenic Acid—Eructation—Zidovudine—acquired immunodeficiency syndrome	0.0105	0.0203	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Amprenavir—acquired immunodeficiency syndrome	0.0102	0.0196	CcSEcCtD
Alpha-Linolenic Acid—FADS2—spinal cord—acquired immunodeficiency syndrome	0.0101	0.021	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—nervous system—acquired immunodeficiency syndrome	0.01	0.0208	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—nervous system—acquired immunodeficiency syndrome	0.01	0.0208	CbGeAlD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Amprenavir—acquired immunodeficiency syndrome	0.00996	0.0192	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Indinavir—acquired immunodeficiency syndrome	0.00978	0.0189	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—central nervous system—acquired immunodeficiency syndrome	0.00965	0.02	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—central nervous system—acquired immunodeficiency syndrome	0.00965	0.02	CbGeAlD
Alpha-Linolenic Acid—FABP7—digestive system—acquired immunodeficiency syndrome	0.00953	0.0198	CbGeAlD
Alpha-Linolenic Acid—FADS2—lung—acquired immunodeficiency syndrome	0.0092	0.0191	CbGeAlD
Alpha-Linolenic Acid—Eructation—Delavirdine—acquired immunodeficiency syndrome	0.00884	0.0171	CcSEcCtD
Alpha-Linolenic Acid—FABP7—spinal cord—acquired immunodeficiency syndrome	0.00875	0.0182	CbGeAlD
Alpha-Linolenic Acid—TRPV1—digestive system—acquired immunodeficiency syndrome	0.00865	0.0179	CbGeAlD
Alpha-Linolenic Acid—FABP3—brain—acquired immunodeficiency syndrome	0.0086	0.0178	CbGeAlD
Alpha-Linolenic Acid—FADS2—nervous system—acquired immunodeficiency syndrome	0.00852	0.0177	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Nevirapine—acquired immunodeficiency syndrome	0.00834	0.0161	CcSEcCtD
Alpha-Linolenic Acid—FADS1—blood—acquired immunodeficiency syndrome	0.00824	0.0171	CbGeAlD
Alpha-Linolenic Acid—FADS2—central nervous system—acquired immunodeficiency syndrome	0.00821	0.017	CbGeAlD
Alpha-Linolenic Acid—Eructation—Ritonavir—acquired immunodeficiency syndrome	0.00818	0.0158	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Nevirapine—acquired immunodeficiency syndrome	0.00817	0.0158	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Nelfinavir—acquired immunodeficiency syndrome	0.00808	0.0156	CcSEcCtD
Alpha-Linolenic Acid—FADS1—bone marrow—acquired immunodeficiency syndrome	0.00797	0.0165	CbGeAlD
Alpha-Linolenic Acid—TRPV1—spinal cord—acquired immunodeficiency syndrome	0.00794	0.0165	CbGeAlD
Alpha-Linolenic Acid—FADS1—spinal cord—acquired immunodeficiency syndrome	0.00794	0.0165	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Abacavir—acquired immunodeficiency syndrome	0.00793	0.0153	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Nelfinavir—acquired immunodeficiency syndrome	0.00791	0.0153	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Saquinavir—acquired immunodeficiency syndrome	0.00787	0.0152	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Abacavir—acquired immunodeficiency syndrome	0.00777	0.015	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—brain—acquired immunodeficiency syndrome	0.00766	0.0159	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—brain—acquired immunodeficiency syndrome	0.00766	0.0159	CbGeAlD
Alpha-Linolenic Acid—FADS1—vagina—acquired immunodeficiency syndrome	0.00764	0.0158	CbGeAlD
Alpha-Linolenic Acid—Eructation—Lamivudine—acquired immunodeficiency syndrome	0.00751	0.0145	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—lymph node—acquired immunodeficiency syndrome	0.0074	0.0154	CbGeAlD
Alpha-Linolenic Acid—FABP7—nervous system—acquired immunodeficiency syndrome	0.00737	0.0153	CbGeAlD
Alpha-Linolenic Acid—FADS1—lung—acquired immunodeficiency syndrome	0.00722	0.015	CbGeAlD
Alpha-Linolenic Acid—FABP7—central nervous system—acquired immunodeficiency syndrome	0.0071	0.0147	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Zidovudine—acquired immunodeficiency syndrome	0.007	0.0135	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Amprenavir—acquired immunodeficiency syndrome	0.0068	0.0131	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—nervous system—acquired immunodeficiency syndrome	0.00669	0.0139	CbGeAlD
Alpha-Linolenic Acid—FADS2—brain—acquired immunodeficiency syndrome	0.00651	0.0135	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.00651	0.0126	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—central nervous system—acquired immunodeficiency syndrome	0.00644	0.0134	CbGeAlD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.00637	0.0123	CcSEcCtD
Alpha-Linolenic Acid—FADS2—lymph node—acquired immunodeficiency syndrome	0.0063	0.0131	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Delavirdine—acquired immunodeficiency syndrome	0.00588	0.0114	CcSEcCtD
Alpha-Linolenic Acid—FABP7—brain—acquired immunodeficiency syndrome	0.00563	0.0117	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Ritonavir—acquired immunodeficiency syndrome	0.00544	0.0105	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.0054	0.0104	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.00539	0.0104	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.0053	0.0102	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Stavudine—acquired immunodeficiency syndrome	0.00527	0.0102	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.00524	0.0101	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.00513	0.0099	CcSEcCtD
Alpha-Linolenic Acid—FADS1—brain—acquired immunodeficiency syndrome	0.00511	0.0106	CbGeAlD
Alpha-Linolenic Acid—TRPV1—brain—acquired immunodeficiency syndrome	0.00511	0.0106	CbGeAlD
Alpha-Linolenic Acid—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00506	0.00977	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.005	0.00964	CcSEcCtD
Alpha-Linolenic Acid—FADS1—lymph node—acquired immunodeficiency syndrome	0.00494	0.0103	CbGeAlD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.00489	0.00944	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00479	0.00925	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00468	0.00903	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.00458	0.00885	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00455	0.00879	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00446	0.0086	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00435	0.0084	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00433	0.00836	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00426	0.00823	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00411	0.00794	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00403	0.00777	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00393	0.00759	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00393	0.00758	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00393	0.00758	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00388	0.00749	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00387	0.00747	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00385	0.00744	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00382	0.00737	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00381	0.00735	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00379	0.00732	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00376	0.00725	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00374	0.00721	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00364	0.00702	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00358	0.00691	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00356	0.00688	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00355	0.00686	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00353	0.00681	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.0035	0.00676	CcSEcCtD
Alpha-Linolenic Acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.0035	0.00676	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0035	0.00675	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00343	0.00662	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00336	0.00649	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00334	0.00645	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.0033	0.00637	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00327	0.00631	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00327	0.0063	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00322	0.00622	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00322	0.00621	CcSEcCtD
Alpha-Linolenic Acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.00319	0.00616	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00319	0.00615	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00313	0.00604	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00312	0.00602	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00311	0.006	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00307	0.00592	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00306	0.00591	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00304	0.00586	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00295	0.0057	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.0029	0.00559	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00289	0.00559	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00287	0.00554	CcSEcCtD
Alpha-Linolenic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00287	0.00554	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00287	0.00553	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00283	0.00546	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.0028	0.00541	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00279	0.00539	CcSEcCtD
Alpha-Linolenic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00536	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00536	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00277	0.00535	CcSEcCtD
Alpha-Linolenic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.00277	0.00535	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00277	0.00534	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00275	0.00531	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00275	0.0053	CcSEcCtD
Alpha-Linolenic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00527	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00526	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00273	0.00526	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0027	0.00522	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00261	0.00505	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00256	0.00495	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.0049	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00252	0.00486	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00251	0.00485	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00247	0.00476	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.00472	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00243	0.00469	CcSEcCtD
Alpha-Linolenic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00465	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00464	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.0024	0.00463	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00237	0.00458	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00235	0.00454	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00233	0.0045	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00227	0.00439	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00226	0.00436	CcSEcCtD
Alpha-Linolenic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00432	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00432	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00213	0.00412	CcSEcCtD
Alpha-Linolenic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00408	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00211	0.00408	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.0021	0.00406	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00204	0.00394	CcSEcCtD
Alpha-Linolenic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00202	0.00391	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00202	0.0039	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00202	0.0039	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00193	0.00372	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00189	0.00364	CcSEcCtD
Alpha-Linolenic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00361	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00361	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.00351	CcSEcCtD
Alpha-Linolenic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00335	CcSEcCtD
Alpha-Linolenic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00332	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00332	CcSEcCtD
